/ Webinars
Accelerating Innovation with J&J
Access webinar replay
Every year Inpart surveys biotechs worldwide on their partnering experiences, their partnering challenges, and their interactions with the world’s largest pharma companies. In our 2023 Partnering 2030 survey, Johnson & Johnson was ranked first amongst top pharma companies for its overall partnering experience.
Panelists
Ajay Gautam
Vice President, Early Innovation Partnering, Johnson & Johnson Innovation, Asia Pacific
Collaborations with biotechs are a key contributor to J&J’s innovation strategy
J&J is one of the largest healthcare companies, operating across the spectrum of healthcare. It is exclusively focused on healthcare innovation to tackle the toughest health challenges, through its two business sectors, J&J Innovative Medicine and J&J MedTech.
Watch the replay to learn:
- What makes partnering with J&J different
- What innovations J&J is focused on in 2024
- How to position your biotech for success at the BIO International Convention
Learn more about Inpart Campaigns
Our bespoke R&D scouting solution allows companies to leverage a global network of academics and biotechs to source new solutions to their requirements and technical challenges.